Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 1998

View Archived Issues

Scriptgen subscribes to Genome Therapeutics' PathoGenome database

Progenics receives milestone payment from Roche for HIV discovery program

Gene linked to inherited glaucoma

Bio-Technology General's OxSODrol study being continued with revised endpoints

Oxford Molecular Group enters research collaboration with Mitsubishi Chemical

Milestone reached in Millennium/Roche collaboration

Clinical update on Advanced Corneal Systems' Vitrase

NeoRx initiates phase I combination therapy trials in multiple myeloma patients

Dusa submits NDA for Levulan PDT of actinic keratoses

Berlex and Chiron file with FDA to treat progressive form of MS

Nihon Nohyaku claims arylpiperidines for schizophrenia, dementia

Banyu isolates new antitumor substance from Streptomyces

Novel antifungal compounds, kinase inhibitors discovered by Shionogi

Platelet aggregation inhibitors in development at Meiji Seika

Toyama describes novel cephalosporins for oral administration

Cephalon licenses Provigil and Myotrophin to Dompe

CHEESE study points to differing immune responses to two different protease inhibitors

IL-2 shown effective in patients with advanced-stage HIV disease

Herceptin licensed to Roche for most markets

Chemokine antagonist inhibits HIV-1 infectivity at nontoxic concentrations

CNI-1493 treatment associated with improvement in mouse model of MS

AIDS vaccine combination shows excellent prophylactic efficacy in clinical trial

Phase I results reported for new AIDS vaccine candidate

FDA approves first complete urine test for HIV

Specific NE inhibitor effective against primary lung tumors and metastases in mice

Chugai to begin clinical testing of anti-IL-6 receptor antibody

S-8510 enhances cognition and acetylcholine release in basal forebrain-lesioned rats

GOG will evaluate Avax Technologies' ovarian cancer vaccine in phase I/II study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...